Разработка и регистрация лекарственных средств (Jan 2019)

METHOD OF DETERMINATION OF 5-METHYL-6-NITRO-7-OXO-1,2,4-TRIAZOLO[1,5-<i>a</i>]PIRIMIDINIDE <i>l-</i>ARGININY - THE ACTIVE COMPONENT OF DRUG «TRIAZID» BY HPLC METHOD

  • A. V. Baklykov,
  • A. A. Tumashov,
  • S. K. Kotovskaya,
  • E. N. Ulomsky,
  • G. L. Rusinov,
  • V. L. Rusinov,
  • G. A. Artem’ev,
  • D. S. Kopchuk,
  • V. N. Charushin

Journal volume & issue
Vol. 0, no. 2
pp. 78 – 83

Abstract

Read online

A procedure for quantitative determination of 5-methyl-6-nitro-7-oxo-1,2,4-triazolo[1,5-a]pirimidinide l -argininy was developed using the HPLC method with UV detection. To achieve the best chromatographic characteristics, it is proposed to use a column with a grafted octadecylsilyl phase 5-100-c18 (EKA, Sweden). The possibility of applying the developed procedure for the technological control of the third stage of the drug «Triazid» preparation was proved by the validation.

Keywords